PhD in Biochemistry. 20+ years of experience in nanoparticles and molecular biology.

Mike helped design and develop the protein drug delivery system central to our breakthrough cancer treatment, FDN Therapy.  He is skilled in nanoparticle synthesis, bioconjugation, activity assays, mouse drug biodistribution by HPLC, cell culture, flow cytometry, RNA-Seq analysis, and other molecular biology techniques.